Selected Titles
Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis
Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress
The latest news and articles
Actero Middle East’s attendance in the 18th Congress of the Iranian Society of Medical Oncology and Hematology
The 18th National Congress of the Oncology and Hematology Society and the Cancer Nursing Conference were held from November 14th to 16th, 2019 at the Evin Hotel in Tehran.
Appreciation of the sacrificers (Isargar) working in Actoverco Company
On the occasion of Arba’een, 150 sacrificers (Isargar) working in the Actover group were appreciated and honored
9th International Congress on Pulmonary disease, Intensive Care and Tuberculosis
The 9th International Congress on Pulmonary disease, Intensive Care and Tuberculosis was held by Dr. Masih Daneshvari Medical Center at Farhikhtegan Hospital in Tehran on October 12-15, 2019.
Actoverco’s attendance at the 3rd international Razavi cardiovascular congress (Caspian and CTO)
The 3rd international Razavi cardiovascular congress was held in Razavi Hospital from 9 to 11 October 2019 for 3 days
A different meeting for cardiologists
On the occasion of World Heart Day, a one-day symposium was hosted by Actoverco Pharmaceutical Company in coordination with the World Heart Federation and accompanied by specialized cardiovascular associations in Iran and attended by more than 150 physicians and cardiologists.
Visit of neurologists and psychologists from Actoverco Pharmaceutical Factories
Actover Group, on the occasion of Doctor’s Day, hosted a group of prominent neurology and psychologist professors of Tehran on Thursday, August 22.
Actoverco’s Active participation in the 21st International Congress on Cardiovascular Updates in Milad Tower International Conference Hall
This congress started on August 20 and will continue until tomorrow, August 23.
Explanation of the manufacturer of the news-making drug “Losartan”
Following the Food and Drug Administration’s order to collect Losartan drug with Indian active ingredient from the supply level, the Iranian company “Actoverco” announced in a statement that it has issued an immediate stop order to sell Losartan drug to distribution companies and the drug collection process from the pharmacies has started.
Conferences and Exhibitions
